Loading...

Carna Biosciences, Inc.

4572.TJPX
Healthcare
Biotechnology
¥302.00
¥2.00(0.67%)

Carna Biosciences, Inc. (4572.T) Stock Competitors & Peer Comparison

See (4572.T) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
4572.T¥302.00+0.67%5.8B-2.48-¥121.65N/A
4587.T¥1,669.00-0.15%215.6B14.62¥114.16N/A
4592.T¥2,335.00-1.06%168.2B-38.20-¥61.12N/A
2160.T¥2,840.00+1.72%143.6B-158.93-¥17.87N/A
4974.T¥906.00-0.88%109.1B104.38¥8.68+1.86%
4565.T¥921.00-0.22%83.3B-35.89-¥25.66N/A
4593.T¥622.00-2.35%68.1B-13.66-¥45.55N/A
4894.T¥6,100.00-0.81%50.1B-75.71-¥80.57N/A
4889.T¥2,903.00-2.45%36.9B325.08¥8.93N/A
4563.T¥74.00+0.00%26.1B-0.65-¥114.38N/A
Showing 1 to 10 of 45 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

4572.T vs 4587.T Comparison August 2025

4572.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4572.T stands at 5.8B. In comparison, 4587.T has a market cap of 215.6B. Regarding current trading prices, 4572.T is priced at ¥302.00, while 4587.T trades at ¥1,669.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4572.T currently has a P/E ratio of -2.48, whereas 4587.T's P/E ratio is 14.62. In terms of profitability, 4572.T's ROE is -0.88%, compared to 4587.T's ROE of +0.26%. Regarding short-term risk, 4572.T is more volatile compared to 4587.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4572.T.Check 4587.T's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;